<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T02:24:44Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/8524" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/8524</identifier><datestamp>2025-10-24T10:32:36Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Current treatment of nosocomial pneumonia and ventilator-associated pneumonia</dc:title>
   <dc:creator>Plata Menchaca, Erika Paola</dc:creator>
   <dc:creator>Ferrer Roca, Ricard</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Plata-Menchaca EP] Grup de Recerca de Shock, Disfunció Orgànica i Ressuscitació, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Ferrer Roca R] Grup de Recerca de Shock, Disfunció Orgànica i Ressuscitació, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Medicina Intensiva, Vall d’Hebron Hospital Universitari, Barcelona, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Pneumònia - Tractament</dc:subject>
   <dc:subject>Medicaments antibacterians - Ús terapèutic</dc:subject>
   <dc:subject>Respiració artificial - Complicacions</dc:subject>
   <dc:subject>DISEASES::Bacterial Infections and Mycoses::Infection::Cross Infection::Pneumonia, Ventilator-Associated</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::Other subheadings::/drug therapy</dc:subject>
   <dc:subject>CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/therapeutic use</dc:subject>
   <dc:subject>ENFERMEDADES::infecciones bacterianas y micosis::infección::infección hospitalaria::neumonía asociada al ventilador</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia</dc:subject>
   <dc:subject>COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/uso terapéutico</dc:subject>
   <dc:description>Nosocomial pneumonia; Treatment; Ventilator-associated pneumonia</dc:description>
   <dc:description>Pneumònia nosocomial; Tractament; Pneumònia associada al ventilador</dc:description>
   <dc:description>Neumonía nosocomial; Tratamiento; Neumonía asociada al ventilador</dc:description>
   <dc:description>Hospital-acquired pneumonia and ventilator-associated pneumonia are severe nosocomial infections leading to high morbidity and mortality. Broad-spectrum antibiotics with coverage against all likely pathogens are recommended by the international guidelines. Inappropriate empirical treatment is one of the most important prognostic factors. Knowledge of local epidemiology and continuous microbiological surveillance is crucial for improving clinical approaches to empirical antimicrobial treatment. The development of protocols and policies for training healthcare professionals on preventive strategies, such as the "Pneumonia Zero" project, and improved implementation of antimicrobial stewardship practices, will aid early de-escalation of antibiotics and prevent resistance.</dc:description>
   <dc:date>2022-11-23T09:26:01Z</dc:date>
   <dc:date>2022-11-23T09:26:01Z</dc:date>
   <dc:date>2022-10</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Plata-Menchaca EP, Ferrer R. Current treatment of nosocomial pneumonia and ventilator-associated pneumonia. Rev Esp Quimioter. 2022 Oct;35(Suppl 3):25–9.</dc:identifier>
   <dc:identifier>1988-9518</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/8524</dc:identifier>
   <dc:identifier>10.37201/req/s03.06.2022</dc:identifier>
   <dc:identifier>36285853</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/8524</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Revista Española de Quimioterapia;35(Suppl 3)</dc:relation>
   <dc:relation>http://www.doi.org/10.37201/req/s03.06.2022</dc:relation>
   <dc:rights>Attribution-NonCommercial 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Sociedad Española de Quimioterapia</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>